Get Started

Artificial Intelligence | Machine Learning | Natural Language Processing Insitro | Predictions for Drug Discovery and Development

South San Francisco, California, United States

Artificial Intelligence | Machine Learning | Natural Language Processing

Insitro | Predictions for Drug Discovery and Development

South San Francisco, California, United States

insitro is an exciting startup company that aims to take a new approach to drug development: one with big data and machine learning at its core.

Total Funding: $243M

Funding Stage: Series B

Business Stage: Growth

Market: B2C

Company Size: 51 to 100

Founded: 2018

Date

Round

$ Raised

Investors

03/15/2021

Series C

$400M

Two Sigma Ventures, T. Rowe Price, Third Rock Ventures, HOF Capital, GV, Foresite Capital, Canadian Pension Plan Investment Board, Casdin Capital, BlackRock Private Equity Partners,, ARCH Venture Partners, Andreessen Horowitz

Date : 03/15/2021

Round: Series C

$ Raised: $400M

Investors: Two Sigma Ventures, T. Rowe Price, Third Rock Ventures, HOF Capital, GV, Foresite Capital, Canadian Pension Plan Investment Board, Casdin Capital, BlackRock Private Equity Partners,, ARCH Venture Partners, Andreessen Horowitz

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

Signup and Get Started

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Insitro

Daphne Koller
Founder and CEO

Insitro - Manage Profile

Insitro is growing. Want to work at Insitro? Insitro is hiring. Join team at Insitro

World's Most Promising AI/ML Startups